Over 10 years experience of Traceability Solutions
By pharmatrax
Category: Technoloy
No Comments
Though AI enhances and drives the financial and manufacturing industries, others remain wary of the investment capital and research needed to insert AI into their…
By pharmatrax
Category: Technoloy
No Comments
Is Japan’s healthcare innovation as good as its technological advances? With its ageing population causing a shortage of labour and subsequent decrease in the overall…
By pharmatrax
Category: Technoloy
No Comments
The pharmaceutical world is in the midst of a sea change. As new deadlines approach for compliance with the Drug Supply Chain Security Act (DSCSA), pharmaceutical…
By pharmatrax
Category: News
No Comments
X-Ray crystallography scientific equipment. Image Credit: Gregory A. Pozhvanov / Shutterstock Drug development relies on having an accurate knowledge of the structure of organic molecules…
By pharmatrax
Category: Technoloy
No Comments
Another innovation hub, in the southern city of Guangzhou, is planned for November. To date, six startups in China and other Asian countries have taken…
By pharmatrax
Category: Technoloy
No Comments
The healthcare sector has been perhaps the slowest of all industries to embrace digitisation — and in fewer countries is this more evident than in…
By pharmatrax
Category: Technoloy
No Comments
The advances in Artificial intelligence (AI) have effectively proliferated into numerous sectors, for example, computer vision, speech recognition and natural language processing. Artificial intelligence is…
By pharmatrax
Category: Technoloy
No Comments
A study that identified 12 novel compounds that may prove valuable against new drug targets for leishmaniasis and Chagas disease was not without complication. Here,…
By pharmatrax
Category: News
No Comments
These 3-D models of a receptor, co-receptor, and ligand demonstrate how the protein painting technology works. Bound proteins in their native form are coated with…
By pharmatrax
Category: Technoloy
No Comments
For the first time, a Toronto-based company called Deep Genomics has discovered a drug target and corresponding candidate using artificial intelligence (AI). The company announced…